2004 Eur J Vasc Endovasc Surg Aspirin Resistance in Cardiovascular Disease – A Review

By 4 June 2019ASPIRIN RESISTANCE
cardiovascular-disease

2004 Eur J Vasc Endovasc Surg Aspirin Resistance in Cardiovascular Disease - A Review

Published on 18th May 2013
cardiovascular-disease

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
906

Joseph S R de Saram CISSP provides thought-provoking insights into Military Intelligence and Law Enforcement, how they operate beyond (as opposed to above) the law, and how their various antics foreseeably lead to the destruction of Fundamental Human Rights. Updates are in progress so check back regularly – verified articles end with . Please feel free to LIKE and SHARE

20130518_000000 JDSSG Borderline ECG Abnormal R and T-waves Dr Victor Lim Parkway Hospital

Aspirin Resistance in Cardiovascular Disease: A Review

Background. Aspirin is effective at reducing the cardiovascular event rate in defined patient groups. The introduction of antiplatelet therapies other than aspirin and the concept of aspirin resistance have led to critical reappraisal of current treatment. This review aims to clarify the evidence for aspirin resistance in patients with atherosclerosis.

Hedding

Enter more text here

cardiovascular-disease

Joseph S R de Saram CISSP FBCS MIEEE MIScT MINCOSE MACS Snr CP

Information Security Architect / Intelligence Analyst / Computer Scientist / Human Rights Activist / COMSEC / SIGINT / TSCM
RHODIUM GROUP